Galera Therapeutics (GRTX) Stock Chart & Stock Price History $0.03 +0.00 (+12.73%) (As of 12/20/2024 03:47 PM ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends Galera Therapeutics Stock Price Performance 5 Day Performance+18.77%1 Month Performance-20.72%3 Month Performance-60.76%6 Month Performance-63.31%Year-To-Date Performance-78.68%1 Year Performance-76.43% Receive GRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Cackling Kamala hates this company (Ad)Do you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. GRTX Stock Chart for Sunday, December, 22, 2024 GRTX Chart by TradingView Galera Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$0.03$0.03+12.73%$0.03$0.03209,647 shs$1.69 million12/19/2024$0.03$0.03+1.85%$0.03$0.0351,563 shs$1.50 million12/18/2024$0.03$0.03+3.45%$0.03$0.03282,749 shs$1.47 million12/17/2024$0.03$0.03-8.42%$0.03$0.0332,192 shs$1.42 million12/16/2024$0.03$0.03-5.00%$0.03$0.03130,516 shs$1.55 million12/13/2024$0.03$0.03-4.46%$0.03$0.02568,905 shs$1.63 million Get the Latest News and Ratings for GRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$0.03$0.03+4.32%$0.03$0.02128,010 shs$1.71 million12/11/2024$0.03$0.03-9.88%$0.04$0.03521,929 shs$1.64 million12/10/2024$0.03$0.03-1.76%$0.04$0.0368,921 shs$1.82 million12/09/2024$0.04$0.03-2.86%$0.04$0.0339,891 shs$1.85 million12/06/2024$0.04$0.04-5.41%$0.04$0.0369,587 shs$1.90 million12/05/2024$0.03$0.04+8.82%$0.04$0.03188,774 shs$2.01 million12/04/2024$0.03$0.03+1.19%$0.04$0.0327,553 shs$1.85 million12/03/2024$0.04$0.03-11.58%$0.04$0.0333,698 shs$1.83 million12/02/2024$0.04$0.04$0.04$0.03134,421 shs$2.07 million11/29/2024$0.04$0.04+1.62%$0.04$0.03101,880 shs$2.05 million11/28/2024$0.04$0.04$0.04$0.0412,339 shs$2.01 million11/27/2024$0.04$0.04-6.57%$0.04$0.0412,339 shs$2.01 million11/26/2024$0.04$0.04+2.86%$0.04$0.0459,877 shs$2.15 million11/25/2024$0.04$0.04-1.41%$0.04$0.04320,745 shs$2.09 million11/22/2024$0.04$0.04-2.49%$0.04$0.0422,604 shs$2.13 million11/21/2024$0.04$0.04-2.20%$0.05$0.0463,380 shs$2.18 million Related Companies ONVO Stock Chart CNSP Stock Chart GTBP Stock Chart SYRS Stock Chart HOTH Stock Chart PPBT Stock Chart IMCC Stock Chart ELAB Stock Chart CANF Stock Chart BMRA Stock Chart Receive GRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GRTX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.